TNXP: Tonmya Approved by FDA
On August 15, 2025, Tonix Pharmaceuticals Holding Corp. (TNXP) announced that the U.S. Food and Drug Administration (FDA) approved Tonmya ...
241 Views
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500
Tonix Pharmaceuticals Holding Corp. (TNXP) recently announced certain preliminary financial information and selected preliminary operating results...
235 Views
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500
Tonix Pharmaceuticals Holding Corp. (TNXP) recently announced certain preliminary financial information and selected preliminary operating results...
277 Views
TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia
On May 12, 2025, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the first quarter of 2025 and provided a business...
370 Views
TNXP: No AdCom Required for TNX-102 SL NDA
On March 24, 2025, Tonix Pharmaceuticals Holding Corp. (TNXP) announced that the FDA will not require an Advisory Committee meeting regarding the...
220 Views